Ozoralizumab (ATN-103) is an anti-TNFalpha humanized antibody. Ozoralizumab is a humanized trivalent nanobody compound that consists of two anti-human TNFalpha nanobodies and an anti-human serum albumin (HSA) nanobody. Ozoralizumab can be used in research of arthritis[1].
Molekulargewicht:
(38.43 kDa)
Reinheit:
99.80
CAS Nummer:
[1167985-17-2]
Target-Kategorie:
TNF Receptor
Anwendungsbeschreibung:
MCE Product type: Inhibitory Antibodies
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten